News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Leheny A. Rachel
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.|
Txns:
| Bought 928 shares
@ $5.2269, valued at
$4.9k
Bought 400 shares
@ $5.25, valued at
$2.1k
|
|
| 06/08/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.|
Txns:
| Bought 1,000 shares
@ $5.1287, valued at
$5.1k
Bought 1,000 shares
@ $5.2478, valued at
$5.2k
|
|
| 06/05/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.|
Txns:
| Bought 1,000 shares
@ $4.8, valued at
$4.8k
|
|
| 06/01/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.|
Txns:
| Bought 1,000 shares
@ $4.21, valued at
$4.2k
|
|
| 05/24/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.|
Txns:
| Bought 3,000 shares
@ $3.3439, valued at
$10k
|
|
| 05/18/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.|
Txns:
| Bought 1,000 shares
@ $2.69, valued at
$2.7k
|
|
| 05/10/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.|
Txns:
| Granted 110,380 options to buy
@ $3.25, valued at
$358.7k
|
|
| 03/22/2023 |
4
| Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc. /DE/|
Txns:
| Granted 356,989 shares
@ $0
Granted 66,228 shares
@ $0
Granted 316,109 shares
@ $0
Granted 11,232 options to buy
@ $2.44, valued at
$27.4k
Granted 76,173 options to buy
@ $6.6, valued at
$502.7k
Granted 30,381 options to buy
@ $6.6, valued at
$200.5k
Granted 13,964 options to buy
@ $7.99, valued at
$111.6k
Granted 19,826 options to buy
@ $7.99, valued at
$158.4k
Granted 3,552 options to buy
@ $10.42, valued at
$37k
Granted 2,030 options to buy
@ $10.42, valued at
$21.2k
Granted 1,062 options to buy
@ $10.42, valued at
$11.1k
|
|
| 10/04/2010 |
4
| Leheny A. Rachel (Director) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Granted 12,000 options to buy
@ $4.19, valued at
$50.3k
|
|
| 09/24/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/05/2010 |
4
| Leheny A. Rachel (Director) has filed a Form 4 on Anthera Pharmaceuticals Inc|
Txns:
| Converted 481,033 shares
@ $0
Converted 68,304 shares
@ $5.25, valued at
$358.6k
Converted 101,301 shares
@ $5.25, valued at
$531.8k
Converted 44,901 shares
@ $6.58, valued at
$295.4k
Granted 215,495 shares
@ $6.58, valued at
$1.4M
Paid exercise price by delivering 23,021 shares
@ $7, valued at
$161.1k
Granted 165,625 shares
@ $7, valued at
$1.2M
Converted 481,033 convertible preferred
@ $0
Granted 12,202 options to buy
@ $7, valued at
$85.4k
Granted 18,304 options to buy
@ $7, valued at
$128.1k
Exercised 120,258 options to buy
@ $1.34, valued at
$161.1k
|
|
|
|